1 year ago

Nanomedicine Market

Browse Full Research

Browse Full Research Report on Nanomedicine Market: On the basis of application, the report segments the global nanomedicine market into oncology, anti-inflammatory, neurology, cardiovascular, anti-infectives, and other applications. In 2012, the overall market was dominated by the oncology segment, which accounted for around 38.0% of the market. This can be attributed to the extensive usage of commercialized nanomedicine products in the field of oncology. However, during the next couple of years, the cardiovascular segment is expected to display the fastest growth owing to the growing geriatric population and increasing demand for nanomedicine-based devices and drugs for the treatment of cardiovascular diseases. The report studies the global nanomedicine market according to its performance in four key regional segments: Asia Pacific, North America, Europe, and Rest of the World. In 2012, North America dominated the overall market and is expected to continue its dominance during the forecast horizon. Advanced healthcare infrastructure has attributed to the growth of the market in this region. However, during the period between 2013 and 2019, Asia Pacific is forecast to expand at a 14.6% CAGR and emerge as the fastest growing region in the market. Rising awareness about

healthcare, coupled with growing prevalence of chronic diseases, has fuelled the nanomedicine market in the region. In countries such as India and China, increased research funding and numerous research collaborations in the field of nanomedicine will further push the market. The report profiles some of the key players in the global nanomedicine market, such as CombiMatrix Corp, Abbott Laboratories, Celgene Corporation, Mallinckrodt plc, Johnson & Johnson, Merck & Co. Inc., GE Healthcare, Pfizer Inc., Nanosphere Inc., UCB SA, Sigma-Tau Pharmaceuticals Inc., and Teva Pharmaceutical Industries Ltd. The report provides insightful information about the key players, including their financial overview, business strategy, product portfolio, and recent developments. Browse Full Press Release on Nanomedicine Market: Press Release About Us Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

Global Human Insulin Market Analysis by Types
Global Arcade Gaming Market Size, Status and Forecast 2022
Spirometer Market Analysis by P&S Market Research
Autologous Stem Cell and Non Stem Cell Based Therapy Market Outlook Report by 2023
Global Biophotonics Market
Global Medical Image Processing Market Outlook Till 2021
Global Clinical Decision Support System (CDSS) Market, 2016–2024
Level Sensors Market, 2016 – 2024
Industrial Packaging Market, 2016 – 2024
Mobile Money Market, 2016–2024
Global Bluetooth Smart and Smart Ready Market Size, Status and Forecast 2022
Global RFID in Healthcare Market, 2015–2021
Global Supply Chain Management BPO Market
Global Tangential Flow Filtration Market, 2016–2024
PCB Design Software Market expected to grow at a CAGR 12.9% during 2016 to 2026
Patient Handling Equipment Market Size, Share, Development and Demand Forecast to 2022
2015 Global Cardiovascular Information System Market Demand till 2019
Concrete Mixing Plant Industry 2015 Market Research Report
Uninterrupted Power Supply Industry Market Research Report 2015